Air Pollution Significantly Diminishes Health Benefits of Exercise, Major Study Finds
A new, comprehensive analysis of over 1.5 million individuals reveals that long-term exposure to air pollution substantially weakens the positive impact of regular physical activity on health, though it doesn’t eliminate it entirely.
Long-term exposure to toxic air can substantially weaken the health benefits of regular exercise, according to research published today in the journal BMC Medicine. The study, conducted by an international team including researchers from University College London (UCL), underscores the critical need to address air quality alongside promoting physical activity for optimal public health.
the research team analyzed data spanning more than a decade from individuals in the U.K., Taiwan, China, Denmark, and the United States. Thay discovered that the protective effects of exercise – specifically, a reduced risk of death from any cause, cancer, and heart disease – were diminished for those living in areas with high levels of air pollution.
The study focused on fine particulate matter (PM2.5), microscopic particles less than 2.5 micrometers in diameter.These particles are particularly dangerous as they can penetrate deep into the lungs and even enter the bloodstream. According to the findings, the health benefits of exercise began to significantly weaken when yearly average PM2.5 levels reached 25 micrograms per cubic meter (μg/m). Alarmingly,nearly half (46%) of the global population currently lives in areas exceeding this threshold.
“Our findings emphasize that exercise remains beneficial even in polluted environments,” stated a lead researcher from National Chung Hsing University, Taiwan. “Though, improving air quality can greatly enhance these health gains.”
The analysis revealed that individuals who engaged in at least two and a half hours of moderate or vigorous exercise per week experienced a 30% lower risk of mortality compared to those with lower activity levels. However, this risk reduction was halved to between 12% and 15% for those residing in areas with high PM2.5 pollution (above 25 μg/m). At even higher pollution levels – exceeding 35 μg/m – the benefits of exercise were further eroded, particularly concerning the risk of death from cancer.Approximately 36% of the world’s population lives in areas with PM2.5 levels above this critical point.
While average PM2.5 levels in the U.K. are currently below these thresholds (averaging 10 μg/m), researchers noted that pollution spikes, particularly during winter months in urban areas, frequently surpass the 25 μg/m level.
“Our study shows that toxic air can to some extent block the benefits of exercise,although not eliminate them,” explained a co-author from UCL’s Department of Behavioral Science & Health. “The findings are further evidence of the damage that fine particle pollution can do to our health. We believe clean air and physical activity are both critically important for healthy aging and so we encourage greater efforts to curb health-harming pollution levels.”
The research team combined data from seven existing studies, including three previously unpublished datasets, utilizing both summary statistics and re-analyzed individual participant data for three of the studies.Researchers accounted for a wide range of confounding factors, including income, education, smoking habits, and pre-existing chronic conditions.
A co-author from UCL’s Department of Epidemiology & Public Health emphasized the importance of continued outdoor exercise, suggesting individuals “check air quality, choose cleaner routes, or ease off intensity on polluted days” to maximize health benefits.
The study acknowledges certain limitations, including a primary focus on high-income countries, potentially limiting the generalizability of findings to regions with even higher pollution levels – often exceeding 50 μg/m in low-income countries. Additionally, the study lacked data on indoor air quality and participants’ dietary habits.
The research involved a collaborative effort from institutions in the U.K., the united States, Australia, and Asia, utilizing data from the UK Biobank for the U.K. portion of the study.
Further details about the study can be found in BMC Medicine (2025). DOI: 10.1186/s12916-025-04496-y.
